FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steffen Zopf

Research Profile

Chemicals & Drugs

Anatomy

Tumor Cell Line

Disorders

Procedures

Living Beings

Mouse
Rats

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
F Knieling; M F Neurath; Thomas Bernatik; R S Goertz; M J Waldner; D Wildner; Steffen Zopf; Deike Strobel
Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome?
Marion Ganslmayer; Christoph Herold; Peter Konturek; Markus F Neurath; Steffen Zopf
Antitumoral efficacy of four histone deacetylase inhibitors in hepatoma in vitro and in vivo.
Steffen Zopf; Beate Alinger; Susanne Gahr; Markus F Neurath; Daniel Neureiter; Matthias Ocker; Pietro Di Fazio
Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steffen Zopf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: F Knieling; M F Neurath; Thomas Bernatik; R S Goertz; M J Waldner; D Wildner; Steffen Zopf; Deike Strobel
Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome?
Ultraschall in der Medizin (Stuttgart, Germany : 1980) 2013;34(1):38-46.
2012: Marion Ganslmayer; Christoph Herold; Peter Konturek; Markus F Neurath; Steffen Zopf
Antitumoral efficacy of four histone deacetylase inhibitors in hepatoma in vitro and in vivo.
Anticancer research 2012;32(12):5263-9.
2012: Steffen Zopf; Beate Alinger; Susanne Gahr; Markus F Neurath; Daniel Neureiter; Matthias Ocker; Pietro Di Fazio
Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.
BMC cancer 2012;12():386.
2012: Susanne Gahr; Anette Pustowka; Deike Strobel; Thaddaeus Till Wissniowski; Steffen Zopf; Matthias Ocker
Combination of the deacetylase inhibitor panobinostat and the multi-kinase inhibitor sorafenib for the treatment of metastatic hepatocellular carcinoma - review of the underlying molecular mechanisms and first case report.
Journal of Cancer 2012;3():158-65.
2011: Marion Ganslmayer; Annette Zimmermann; Steffen Zopf; Christoph Herold
Combined inhibitors of angiogenesis and histone deacetylase: efficacy in rat hepatoma.
World journal of gastroenterology : WJG 2011;17(31):3623-9.
2009: Steffen Zopf; Jakob Flämig; Heide Schmid; Nicolai Miosge; Sabine Blaschke; Eckhart G Hahn; Gerhard A Müller; Rolf W Grunewald
Localization of the polyol pathway in the human kidney.
Histology and histopathology 2009;24(4):447-55.
2009: Sebastian Stintzing; C Schmitt; Matthias Ocker; Marion Ganslmayer; Steffen Zopf; S Gahr; Eckhart Hahn; Christoph Herold
Liver function under interferon/ribavirin therapy of chronic hepatitis C.
Hepato-gastroenterology 2009;56(90):462-5.
2009: Steffen Zopf; Christoph Herold; Eckhart G Hahn; Marion Ganslmayer
Peginterferon alfa-2a relapse rates depend on weight-based ribavirin dosage in HCV-infected patients with genotype 1: results of a retrospective evaluation.
Scandinavian journal of gastroenterology 2009;44(4):486-90.
2007: Steffen Zopf; Daniel Neureiter; Stelios Bouralexis; Tobias Abt; Keith B Glaser; Kinya Okamoto; Marion Ganslmayer; Eckhart Hahn; Christoph Herold; Matthias Ocker
Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
International journal of oncology 2007;31(6):1391-402.
2007: Susanne Gahr; Matthias Ocker; Marion Ganslmayer; Steffen Zopf; Kinya Okamoto; Andrea Hartl; Sandra Leitner; Eckhart Hahn; Christoph Herold
The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells.
International journal of oncology 2007;31(3):567-76.
2007: Kinya Okamoto; Matthias Ocker; Daniel Neureiter; Otto Dietze; Steffen Zopf; Eckhart Hahn; Christoph Herold
bcl-2-specific siRNAs restore gemcitabine sensitivity in human pancreatic cancer cells.
Journal of cellular and molecular medicine 2007;11(2):349-61.
2007: Daniel Neureiter; Steffen Zopf; Thorsten Leu; Otto Dietze; Cornelia Hauser-Kronberger; Eckhart Hahn; Christoph Herold; Matthias Ocker
Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models.
Scandinavian journal of gastroenterology 2007;42(1):103-16.
2005: Matthias Ocker; Marion Ganslmayer; Steffen Zopf; Susanne Gahr; Christopher Janson; Eckhart Hahn; Christoph Herold
Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy.
World journal of gastroenterology : WJG 2005;11(35):5521-4.
2005: Matthias Ocker; Daniel Neureiter; M Lueders; Steffen Zopf; Marion Ganslmayer; Eckhart Hahn; Christoph Herold; Detlef Schuppan
Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.
Gut 2005;54(9):1298-308.
2005: Matthias Ocker; Abdullah Alajati; Marion Ganslmayer; Steffen Zopf; Mike Lüders; Daniel Neureiter; Eckhart Hahn; Detlef Schuppan; Christoph Herold
The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells.
Journal of cancer research and clinical oncology 2005;131(6):385-94.
2005: Marion Ganslmayer; Matthias Ocker; Steffen Zopf; Detlef Schuppan; Eckhart Hahn; Christoph Herold
Hepatocellular carcinomas do not compromise quantitative tests of liver function.
Hepato-gastroenterology 2005;52(63):881-4.
2005: Daniel Neureiter; Steffen Zopf; Arno Dimmler; Sebastian Stintzing; Eckhart Hahn; Thomas Kirchner; Christoph Herold; Matthias Ocker
Different capabilities of morphological pattern formation and its association with the expression of differentiation markers in a xenograft model of human pancreatic cancer cell lines.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2005;5(4-5):387-97.
2004: Marion Ganslmayer; Matthias Ocker; Gabi Kraemer; Steffen Zopf; Eckhart Hahn; Detlef Schuppan; Christoph Herold
The combination of tamoxifen and 9cis retinoic acid exerts overadditive anti-tumoral efficacy in rat hepatocellular carcinoma.
Journal of hepatology 2004;40(6):952-6.
2004: Matthias Ocker; Christoph Herold; Marion Ganslmayer; Steffen Zopf; Eckhart Hahn; Detlef Schuppan
Potentiated anticancer effects on hepatoma cells by the retinoid adapalene.
Cancer letters 2004;208(1):51-8.
2004: Marion Ganslmayer; Matthias Ocker; Steffen Zopf; Sandra Leitner; Eckhart Hahn; Detlef Schuppan; Christoph Herold
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells.
Oncology reports 2004;11(5):943-50.
2003: Christoph Herold; Marion Ganslmayer; Matthias Ocker; S Blauberger; Steffen Zopf; Eckhart Hahn; Detlef Schuppan
Overadditive anti-proliferative and pro-apoptotic effects of a combination therapy on colorectal carcinoma cells.
International journal of oncology 2003;23(3):751-6.
2003: Christoph Herold; Marion Ganslmayer; Matthias Ocker; Steffen Zopf; Barbara Gailer; Eckhart Hahn; Detlef Schuppan
Inducibility of microsomal liver function may differentiate cirrhotic patients with maintained compared with severely compromised liver reserve.
Journal of gastroenterology and hepatology 2003;18(4):445-9.